Clinical Trials Browser

Phase 1 × Colorectal Neoplasms × Dasatinib × Clear all

NCT04164069 2024-12-27

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00501410 2019-08-28

FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer

Phase 1 Completed

86 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00920868 2016-02-03

XAD

Phase 1 Completed

22 enrolled

Gastrointestinal

Colorectal Neoplasms